IP Library Granted Patent US 9,700,627
Granted Patent B2
US 9,700,627 · App. 14/811,613 · Granted Jul 11, 2017

Biodegradable poly (beta-amino esters) and uses thereof

Inventors: Robert S. Langer (Newton, MA); David M. Lynn (Middleton, WI); David A. Putnam (Cambridge, MA); Mansoor M. Amiji (Attleboro, MA); Daniel Griffith Anderson (Framingham, MA)
Assignee: Massachusetts Institute of Technology
A61K47/34A61K9/5146A61K31/711A61K31/713A61K47/482A61K47/48192A61K47/48884B82Y5/00C08G63/685C08G73/02C08G73/0273C08G73/06C08G73/0611C08G73/0616C12N15/88
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,700,627
App. No.
14/811,613
Granted
Jul 11, 2017
Kind
B2
Abstract

Poly(β-amino esters) prepared from the conjugate addition of bis(secondary amines) or primary amines to a bis(acrylate ester) are described. Methods of preparing these polymers from commercially available starting materials are also provided. These tertiary amine-containing polymers are preferably biodegradable and biocompatible and may be used in a variety of drug delivery systems. Given the poly(amine) nature of these polymers, they are particularly suited for the delivery of polynucleotides. Nanoparticles containing polymer/polynucleotide complexes have been prepared. The inventive polymers may also be used to encapsulate other agents to be delivered. They are particularly useful in delivering labile agents given their ability to buffer the pH of their surroundings.

Claims (43)

1. A polymer of the formula:

or a salt thereof, wherein:

linker A and linker B are each independently selected from the group consisting of carbon chains of 1 to 30 carbon atoms, heteroatom-containing carbon chains of 1 to 30 atoms, and carbon chains and heteroatom-containing carbon chains with at least one substituent selected from the group consisting of branched and unbranched alkyl, branched and unbranched alkenyl, branched and unbranched alkynyl, amino, alkylamino, dialkylamino, trialkylamino, aryl, ureido, heterocyclic, aromatic heterocyclic, cyclic, aromatic cyclic, halogen, hydroxyl, alkoxy, cyano, amide, carbamoyl, carboxylic acid, ester, carbonyl, carbonyldioxyl, alkylthioether, and thiol groups;

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 are each independently selected from the group consisting of hydrogen, branched and unbranched alkyl, branched and unbranched alkenyl, branched and unbranched alkynyl, aryl, halogen, hydroxyl, alkoxy, carbamoyl, carboxyl ester, carbonyldioxyl, amide, thiohydroxyl, alkylthioether, amino, alkylamino, dialkylamino, trialkylamino, cyano, ureido, a substituted alkanoyl group, cyclic, cyclic aromatic, heterocyclic, and aromatic heterocyclic groups, each of which is optionally independently substituted with at least one substituent selected from the group consisting of branched and unbranched alkyl, branched and unbranched alkenyl, branched and unbranched alkynyl, amino, alkylamino, dialkylamino, trialkylamino, aryl, ureido, heterocyclic, aromatic heterocyclic, cyclic, aromatic cyclic, halogen, hydroxyl, alkoxy, cyano, amide, carbamoyl, carboxylic acid, ester, carbonyl, carbonyldioxyl, alkylthioether, and thiol groups; and

n is an integer between 5 and 10,000;

provided that the polymer comprises at least two different types of

moieties.

2. The polymer of claim 1 , wherein the linker A is polyethylene or polyethylene glycol.

3. The polymer of claim 1 , wherein the linker B is polyethylene or polyethylene glycol.

4. The polymer of claim 1 , wherein the molecular weight of the polymer is between 1,000 g/mol and 100,000 g/mol.

5. A pharmaceutical composition comprising an agent to be delivered and a polymer of claim 1 .

6. The pharmaceutical composition of claim 5 , wherein the agent is a small molecule.

7. The pharmaceutical composition of claim 5 , wherein the agent is an antisense agent.

8. The pharmaceutical composition of claim 5 , wherein the agent is a peptide or protein.

9. The pharmaceutical composition of claim 5 , wherein the agent is a polynucleotide.

10. The pharmaceutical composition of claim 9 , wherein the polynucleotide is DNA or RNA.

11. The pharmaceutical composition of claim 9 , wherein the polynucleotide is plasmid DNA.

12. The pharmaceutical composition of claim 9 , wherein the polynucleotide is RNAi.

13. The pharmaceutical composition of claim 9 , wherein the polynucleotide encodes a protein or peptide.

14. The polymer of claim 1 , wherein the polymer is prepared by a method comprising reacting at least two different types of bis(secondary amine) monomers with one or more types of bis(acrylate ester) monomers under suitable conditions.

15. The polymer of claim 14 , wherein at least one bis(acrylate ester) monomer is of the formula

16. A method of synthesizing a polymer of claim 14 , the method comprising

reacting at least two different types of bis(secondary amine) monomers with one or more types of bis(acrylate ester) monomers under suitable conditions to form the polymer.

17. The polymer of claim 14 , wherein at least one bis(secondary amine) monomer is N,N′-dimethylethylenediamine or 1,2-bis(N-ethylamino)ethylene.

18. The polymer of claim 1 , wherein linker A is a carbon chain of 1 to 15 carbon atoms.

19. The polymer of claim 1 , wherein linker B is a carbon chain of 1 to 15 carbon atoms.

20. The polymer of claim 1 , wherein linker B is a heteroatom-containing carbon chain of 1 to 15 atoms long.

21. The polymer of claim 1 , wherein at least one instance of R 1 is hydrogen or branched or unbranched alkyl.

22. The polymer of claim 1 , wherein at least one instance of R 2 is hydrogen or branched or unbranched alkyl.

23. The polymer of claim 1 , wherein each of R 3 and R 6 is hydrogen.

24. The polymer of claim 1 , wherein each of R 4 , R 5 , R 7 , and R 8 is hydrogen.

25. The polymer of claim 1 , wherein n is an integer between 10 and 500.

26. The polymer of claim 1 , wherein linker A is a heteroatom-containing carbon chain of 1 to 15 atoms long.

27. The polymer of claim 1 , wherein the molecular weight of the polymer is between 4,000 g/mol and 50,000 g/mol.

28. A polymer of the formula:

or a salt thereof, wherein:

linker A and linker B are each independently selected from the group consisting of carbon chains of 1 to 30 carbon atoms, heteroatom-containing carbon chains of 1 to 30 atoms, and carbon chains and heteroatom-containing carbon chains with at least one substituent selected from the group consisting of branched and unbranched alkyl, branched and unbranched alkenyl, branched and unbranched alkynyl, amino, alkylamino, dialkylamino, trialkylamino, aryl, ureido, heterocyclic, aromatic heterocyclic, cyclic, aromatic cyclic, halogen, hydroxyl, alkoxy, cyano, amide, carbamoyl, carboxylic acid, ester, carbonyl, carbonyldioxyl, alkylthioether, and thiol groups;

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 are each independently selected from the group consisting of hydrogen, branched and unbranched alkyl, branched and unbranched alkenyl, branched and unbranched alkynyl, aryl, halogen, hydroxyl, alkoxy, carbamoyl, carboxyl ester, carbonyldioxyl, amide, thiohydroxyl, alkylthioether, amino, alkylamino, dialkylamino, trialkylamino, cyano, ureido, a substituted alkanoyl group, cyclic, cyclic aromatic, heterocyclic, and aromatic heterocyclic groups, each of which is optionally independently substituted with at least one substituent selected from the group consisting of branched and unbranched alkyl, branched and unbranched alkenyl, branched and unbranched alkynyl, amino, alkylamino, dialkylamino, trialkylamino, aryl, ureido, heterocyclic, aromatic heterocyclic, cyclic, aromatic cyclic, halogen, hydroxyl, alkoxy, cyano, amide, carbamoyl, carboxylic acid, ester, carbonyl, carbonyldioxyl, alkylthioether, and thiol groups;

each of R 9 and R 10 is independently selected from the group consisting of hydrogen, branched and unbranched alkyl, branched and unbranched alkenyl, branched and unbranched alkynyl, aryl, halogen, hydroxyl, alkoxy, carbamoyl, carboxyl ester, carbonyldioxyl, amide, thiohydroxyl, alkylthioether, amino, alkylamino, dialkylamino, trialkylamino, cyano, ureido, a substituted alkanoyl group, cyclic, cyclic aromatic, heterocyclic, and aromatic heterocyclic groups, each of which is optionally independently substituted with at least one substituent selected from the group consisting of branched and unbranched alkyl, branched and unbranched alkenyl, branched and unbranched alkynyl, amino, alkylamino, dialkylamino, trialkylamino, aryl, ureido, heterocyclic, aromatic heterocyclic, cyclic, aromatic cyclic, halogen, hydroxyl, alkoxy, cyano, amide, carbamoyl, carboxylic acid, ester, carbonyl, carbonyldioxyl, alkylthioether, and thiol groups, and the counter anion is selected from the group consisting of chloride, fluoride, bromide, iodide, sulfate, nitrate, fumarate, acetate, carbonate, stearate, laurate, and oleate; and

n is an integer between 5 and 10,000;

provided that the polymer comprises at least two different types of

moieties.

29. The polymer of claim 28 , wherein one or both of R 9 and R 10 are hydrogen.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 30, 2018
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 046269/0598 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2015
From: LANGER, ROBERT S.; LYNN, DAVID M.; ANDERSON, DANIEL G.; AMIJI, MANSOOR M.; PUTNAM, DAVID
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 036474/0946 →
Continuity (6)
Continuation 14029552 · Sep 17, 2013
Continuation 11099886 · Apr 6, 2005
Division 09969431 · Oct 2, 2001
Provisional Application 60305337 · Jul 13, 2001
Provisional Application 60239330 · Oct 10, 2000
Related Publication 20160022821A1 · Jan 28, 2016